ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Consumerinfo for CoAprovel® 150/12,5; 300/12,5; 300/25:Sanofi-Aventis (Suisse) SA
Complete consumer infoPrint 
EffectsAmendmentsContra IndicationPrecautionsPregnancyUsageUnwanted effectsGeneral advice
Composition.PackagesSwissmedic-Nr.Registration ownerLast update of information 

Zulassungsinhaberin

sanofi-aventis (schweiz) sa, 1214 Vernier

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home